Cargando…
Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis
BACKGROUND: Thromboembolic events are common complications of COVID-19. Clinical study results on safety and efficacy of anticoagulation in COVID-19 are controversial. MATERIAL AND METHODS: This report updates our systematic review and random-effects meta-analysis on randomized controlled trials (RC...
Autores principales: | Reis, Stefanie, Popp, Maria, Schießer, Selina, Metzendorf, Maria-Inti, Kranke, Peter, Meybohm, Patrick, Weibel, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451936/ https://www.ncbi.nlm.nih.gov/pubmed/36113402 http://dx.doi.org/10.1016/j.thromres.2022.09.001 |
Ejemplares similares
-
Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis
por: Reis, Stefanie, et al.
Publicado: (2021) -
Ivermectin for preventing and treating COVID‐19
por: Popp, Maria, et al.
Publicado: (2022) -
Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19
por: Reis, Stefanie, et al.
Publicado: (2022) -
Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19
por: Reis, Stefanie, et al.
Publicado: (2023) -
Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges
por: Popp, Maria, et al.
Publicado: (2022)